The global ECMO devices market is projected to grow at a CAGR of 12.2% during the forecast period, from 2021-2028. This report provides an overview of the global ECMO devices market in terms of value by type (VV ECMO, VA ECMO, AV ECMO), applications, and region. The study includes drivers and restraints affecting the growth of this industry along with their impact on demand over the forecast period.
ECMO refers to Extracorporeal Membrane Oxygenation, and it is a treatment for severe respiratory failure. A machine that provides ECMO removes the oxygen-less blood from an individual's body and pumps it through a membrane giving them oxygen. Until now, this has been done only in very few hospitals worldwide because of its complexity--that’s changing with the introduction of more efficient devices.
An ECMO device is a life-supporting machine that acts as an artificial lung and heart. Theoretically, it could be used to treat any condition in which the organs are failing, such as multiple organ failure or severe sepsis. In practice, however, ECMO has not been shown to help people with irreversible brain injuries or who have suffered strokes.
On the basis of type, ECMO devices are segmented into VV ECMO, VA ECMO, and AV ECMO.
VV ECMO refers to venovenous extracorporeal membrane oxygenation. It is a type of Extracorporeal Membrane Oxygenation (ECMO), which is an extracorporeal circulation system that uses artificial means to pump blood from the venous system, through the pulmonary bypass circuit and then back into the arterial system. A VV device pumps blood from the body into a membrane outside of it to increase oxygenation in areas that would otherwise not receive enough air.
A vacuum-assisted ECMO device is a type of extracorporeal membrane oxygenation that uses an artificial pump to create and maintain the blood flow necessary for survival. It provides cardiopulmonary support by withdrawing venous blood, removing carbon dioxide from it, and returning oxygenated blood back into the body via two cannulas inserted in large veins.
A VA ECMO device works when the patient's oxygen-depleted blood is pumped from a vein near the heart to an artificial lung, called a membrane oxygenator, where it picks up the fresh air and returns to circulate through the body. When used as cardiopulmonary support during surgery in place of life support machines such as ventilators, this type of system is known as extracorporeal circulation (ECC). The person who needs help with breathing can wear only one mask connected to both types of apparatus. A VA device sends only venous return (deoxygenated) back through an external membrane by way of gravity or vacuum pressure for re-oxygenation purposes; this is usually used on patients with pulmonary hypertension who are too weak to breathe effectively on their own.
VA ECMO devices are capable of being mounted on rolling platforms or ruggedized for transport by military personnel. It allows medical professionals easier mobility and access than simply carrying around another machine that weighs more. VA ECMO devices are the most logical choice for military personnel and civilians due to their portability, durability, and low cost. Virtually all VA ECMOs have at least two types: single-lung systems (SL).
An AV ECMO is a device that provides respiratory support to patients with severe lung failure. This type of ECMO system can be used as an alternative treatment for neonatal infants, children, and adults who are unable to breathe on their own because of acute respiratory distress syndrome (ARDS). An AV system does both simultaneously: It removes deoxygenated blood from the body and returns it with extra oxygen after passing through a filter inside a membrane outside of the patient's body--this is often called "extracorporeal circulation.
On the basis of application, the global ECMO devices market is segmented into hospitals, diagnostic centers, clinics, and ambulatory surgical centers.
An ECMO device can provide respiratory support to patients with severe lung failure. It works by taking blood from a patient and pumping it through an artificial heart or mechanical pump outside of the body, which removes deoxygenated blood and returns it with oxygen after passing through a filter inside a membrane called "extracorporeal circulation." This type of ECMO system is often used as an alternative treatment for neonatal infants, children, and adults who are unable to breathe on their own because of acute respiratory distress syndrome (ARDS).
ECMO devices are often utilized in diagnostic centers for longer procedures. VV ECMO devices can be attached to a patient and then the physician, with assistance from an anesthesiologist, can use it during surgery without having to stop operating or using instruments on another part of the body.
ECMO devices are used in clinics to provide respiratory and circulatory support for patients with cardiac or pulmonary complications. ECMO is a life-saving procedure if performed early enough. It offers an alternative option when other treatments have failed, such as mechanical ventilation or surgical intervention. The device is used for the treatment of respiratory failure, shock, and cardiac arrest. In addition, it also can be applied to patients with acute myocardial infarction or septic shock among others.
The application of ECMO devices in ambulatory surgical centers is growing. The demand for these types of facilities has grown due to the need for minimally invasive surgeries, which have been less risky and more cost-effective than traditional surgery methods. Patients who undergo this type of treatment are at a lower risk of infection because there’s no skin incision made by instruments like a scalpel or laser knife.
On the basis of region, the global ECMO devices market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the largest market for ECMO devices in terms of revenue generation and this trend will continue during the forecast period 2021-2028.
In the region of North America, in addition to the U.S., Canada also emerges as a major player in this regional market for ECMO Devices due to the high prevalence rate of cardiovascular diseases such as atherosclerosis and stroke among Canadians.
The type of application for which the device has been used also varies across different regions such as hospitals, diagnostic centers, clinics, and ambulatory surgical centers in North America (US). In the European region, Hospital application dominates this regional market for ECM Devices due to the high prevalence rate of cardiovascular diseases among Europeans.
In the Asia Pacific region, hospital applications are the dominant player followed by diagnostic centers. Ambulatory surgical centers are emerging as a new entrant in this regional market for ECM Devices mainly because of increasing incidence rates of chronic obstructive pulmonary disease (COPD) cases globally leading to higher incidences of ventilation-related disorders like ARDS.
In the Latin American region, hospital application is the largest end-user of ECM Devices because of its high prevalence rate of cardiovascular diseases among Latins and strict regulatory norms for clinical trials in this region. In the Middle East & Africa region, hospitals are the dominant customer due to higher incidences rates of chronic respiratory disease cases such as COPD.
-Increasing incidence of cardiovascular diseases and respiratory disorders, which are the major cause for ECMO.
-Availability of new technologies including computerized respirators etc., will provide better treatment options to patients with difficult breathing patterns or lung injury.
-Increase in the number of surgeries like Coronary Artery Bypass Grafting (CABG), Mitral Valve Repair Surgery (MVR) among others that can be done successfully only if a patient has been put on ECMO. This is expected to improve growth prospects over the coming years as more hospitals adopt this procedure due to its benefits such as the reduced risk of mortality, faster recovery time post-surgery, prolonged life span quality improvements, etc.,
-Lower costs for devices compared with conventional ventilation techniques, will be a major factor to drive the market over the coming years.
Up Market Research published a new report titled “ECMO Devices Market research report which is segmented by Types (VV ECMO, VA ECMO, AV ECMO), By Applications (Hospitals, Diagnostic Centre, Clinics, Ambulatory Surgical Centre), By Players/Companies Microport Scientific, Sorin, Terumo Cardiovascular, Medtronic, Nipro Medical, Medos, Maquet Holding”. As per the study, the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||ECMO Devices Market Research Report|
|By Type||VV ECMO, VA ECMO, AV ECMO|
|By Application||Hospitals, Diagnostic Centre, Clinics, Ambulatory Surgical Centre|
|By Companies||Microport Scientific, Sorin, Terumo Cardiovascular, Medtronic, Nipro Medical, Medos, Maquet Holding|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||225|
|Number of Tables & Figures||158|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type VV ECMO, VA ECMO, AV ECMO and By Application Hospitals, Diagnostic Centre, Clinics, Ambulatory Surgical Centre.
Some of the companies that are profiled in this report are:
ECMO Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the ECMO Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the ECMO Devices Market Report:
Some other reports from this category!